@文章{信息:doi/10.2196/30340，作者="Becker, Elisabeth RB和Shegog, Ross和Savas, Lara S和Frost, Erica L和Coan, Sharon P和Healy, C Mary和Spinner, Stanley W和Vernon, Sally W"，标题="父母对移动健康干预影响人类乳头瘤病毒疫苗接种决策的经验:混合方法研究"，期刊="JMIR儿科父母"，年="2022"，月="2月"，日="21"，卷="5"，数="1"，页数="e30340"，关键词="人类乳头瘤病毒;疫苗接种;用户体验;父母;移动健康;人乳头状瘤病毒;疫苗;人乳头状瘤病毒疫苗;父母;儿科; sexual health; cervical cancer; adolescents; app; application", abstract="Background: Human papillomavirus (HPV)-attributed cancers are preventable, yet HPV vaccination rates severely lag behind other adolescent vaccinations. HPVcancerFree (HPVCF) is a mobile health (mHealth) intervention developed to influence parental HPV vaccination decision making by raising awareness of HPV, reducing HPV vaccination barriers, and enabling HPV vaccination scheduling and reminders through a smartphone app. Evaluating the user experience of mHealth interventions is a vital component in assessing their quality and success but tends to be underreported in mHealth intervention evaluation. Objective: We aimed to evaluate the user experience of HPVCF, an HPV cancer prevention app designed for a pediatric clinic network, using mixed methods data collected from log files, survey measures, and qualitative feedback. Methods: Study data were evaluated from parents in a large US pediatric clinic network using HPVCF in the treatment study condition of a group randomized controlled trial. Log data captured HPVCF retention and use. Postintervention rating scales and items assessed HPVCF utility, usefulness, understandability, appeal, credibility, and perceived impact. Overall quality was evaluated using the user version of the Mobile Application Rating Scale (uMars). Open-ended responses assessed parent recommendations for HPVCF enhancement. Results: The 98 parents were mainly female (n=94, 96{\%}), 41 (5.67) years of age, college educated (n=55, 56{\%}), and White and non-Hispanic (n=55, 56{\%}) and had private health insurance for their children (n=75, 77{\%}). Parents used HPVCF 197 times, with the average visit duration approximating 3.5 minutes. The uMARS app quality score was positively skewed (4.2/5.0). Mean ratings were highest for information (4.46 [SD 0.53]) and lowest for engagement (3.74 [SD 0.69]). In addition, of 95 parents, 45 (47{\%}) rated HPVCF as helpful in HPV vaccination decision making and 16 (17{\%}) attributed HPV vaccine initiation to HPVCF. Parents reported that HPVCF increased their awareness (84/95, 88{\%}), knowledge (84/95, 88{\%}), and HPV vaccination intentions (64/95, 67{\%}). Most of the 98 parents rated the 4 HPVCF components as useful (72-92 [73{\%}-94{\%}]). Parents also agreed that HPVCF is clear (86/95, 91{\%}), accurate (86/95, 91{\%}), and more helpful than other HPV vaccine information they had received (89/95, 94{\%}) and that they would recommend it to others (81/95, 85{\%}). In addition, parents suggested ways to increase awareness and engagement with the app, along with opportunities to enhance the content and functionality. Conclusions: HPVCF was well received by parents and performed well on indicators of quality, usefulness, utility, credibility, and perceived impact. This study contributes a multimethod and multimeasure evaluation to the growing body of literature focused on assessing the user experience of patient-focused technology-mediated applications for HPV education. ", issn="2561-6722", doi="10.2196/30340", url="https://pediatrics.www.mybigtv.com/2022/1/e30340", url="https://doi.org/10.2196/30340", url="http://www.ncbi.nlm.nih.gov/pubmed/35188469" }